Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cy5 maleimide non sulfonated 5mg'

Search results for: 'cy5 maleimide non sulfonated 5mg'

Items 61-70 of 95

Page
per page
  1. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    Target: EGFR|ErbB
    Summary: ErbB inhibitor
      ≥23.7 mg/mL
  2. BAY 61-3606
    A3227 BAY 61-3606
    Target: Syk
    Summary: Syk Inhibitor
      insoluble in H2O; insoluble in EtOH; ≥7.94 mg/mL
  3. R788 disodium
    A8332 R788 disodium
    Target: Syk
    Summary: Syk inhibitor,ATP competitive and potent
      ≥62.4 mg/mL
  4. Ponatinib (AP24534)
    A5467 Ponatinib (AP24534)
     1 Citation
    Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src
    Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor
      ≥53.3 mg/mL
  5. NVP-AEW541
    A2278 NVP-AEW541
    Target: Insulin Receptor
    Summary: IGF-IR inhibitor, novel, potent and selective
      ≥22 mg/mL
  6. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  7. SGX-523
    A1196 SGX-523
     1 Citation
    Target: MET
    Summary: MET inibitor, highly selective, ATP-competitive
      ≥17.95 mg/mL
  8. Saracatinib (AZD0530)
    A2133 Saracatinib (AZD0530)
     3 Citation
    Target: Src
    Summary: Src/Abl inhibitor,potent and selective
      ≥27.1 mg/mL
  9. DCC-2036 (Rebastinib)
    B1404 DCC-2036 (Rebastinib)
    Target: FLT3|Bcr-Abl|Tie-2|KDR
    Summary: Bcr-Abl inhibitor
      ≥27.7 mg/mL
  10. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2 inhibitor,ATP-competitive
      insoluble in H2O; ≥18.5 mg/mL

Items 61-70 of 95

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 6item
  2. Axl 4item
  3. ALK 8item
  4. c-Kit 1 item
  5. c-MET 8item
  6. c-RET 1 item
  7. CSF-1R 1 item
  8. EGFR 14item
  9. FAK 5item
  10. FGFR 8item
  11. FLT3 6item
  12. HER2 6item
  13. IGF1R 2item
  14. IRAK 1 item
  15. ITK 1 item
  16. LRRK2 3item
  17. PDGFR 4item
  18. Pyk2 2item
  19. Spleen Tyrosine Kinase (Syk) 5item
  20. Src 7item
  21. Tie-2 2item
  22. Trk 2item
  23. VEGFR 16item
Specificity
  1. Selective 71item
Reversibility
  1. Reversible 8item
  2. Irreversible 8item
Target
  1. Raf 1 item
  2. Aurora Kinases 2item
  3. CSF-1R 2item
  4. MER 1 item
  5. FLT3 9item
  6. Eph Receptors 1 item
  7. VEGFR 20item
  8. PDGFR 13item
  9. c-Kit 4item
  10. RET 2item
  11. IRAK 1 item
  12. Bcr-Abl 6item
  13. FGFR 12item
  14. MET 7item
  15. Src 9item
  16. Trk Receptors 2item
  17. STAT 1 item
  18. EGFR 14item
  19. FAK 5item
  20. BMP and Other Activin Receptors 1 item
  21. JAK 1 item
  22. Syk 5item
  23. ErbB 2item
  24. c-MET 4item
  25. PKC 1 item
  26. Lyn 1 item
  27. HER2 3item
  28. Pyk2 3item
  29. LRRK2 3item
  30. Insulin and Insulin-like Receptors 2item
  31. ALK 6item
  32. ROS1 2item
  33. Insulin-like growth factors (IGFs) 1 item
  34. Angiotensin-Converting Enzymes (ACEs) 1 item
  35. Tie-2 3item
  36. RSK 1 item
  37. p70 S6K 1 item
  38. Ron 1 item
  39. 5-Lipoxygenases 1 item
  40. Insulin Receptors 1 item
  41. IRG-1R 1 item
  42. ZAP-70 1 item
  43. Flk-1 1 item
  44. c-RET 1 item
  45. TAM kinase 1 item
  46. KDR 1 item
  47. Fyn kinase 1 item
  48. AXL 1 item
  49. insulin 1 item
  50. Lyn kinase 1 item
  51. ITK 1 item
  52. PTK 1 item
  53. Flk1 1 item
  54. YES 1 item
  55. Fyn 1 item
  56. enoyl-acyl-carrier protein reductase 1 item
  57. tropomyosin receptor kinase 1 item
  58. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 4item
  3. Adrenocortical Carcinoma 1 item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 2item
  6. Bladder Carcinoma 1 item
  7. Breast Cancer 14item
  8. Cancer 69item
  9. Cholangiocarcinoma 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 2item
  12. Colon Carcinoma 2item
  13. Colorectal Cancer 6item
  14. Glioblastoma 4item
  15. Glioma 4item
  16. Hepatocellular Carcinoma 3item
  17. Lung Cancer 5item
  18. Lung Carcinoma 4item
  19. Lymphoma 4item
  20. Multiple Myeloma 4item
  21. Neuroblastoma 2item
  22. Non-small Cell Lung Cancer 4item
  23. Ovarian Cancer 5item
  24. Pancreatic Cancer 9item
  25. Prostate Cancer 4item
  26. Pulmonary Arterial Hypertension 1 item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 1 item
  29. Rheumatoid Arthritis 2item
  30. Thyroid Cancer 3item